CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS (Unaudited) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2024		Mar. 31, 2023
Net revenue	$ 61,082		$ 52,036
Cost of goods sold	13,842	[1]	10,229
Gross profit	47,240		41,807
Operating expenses
Research and development costs	7,584		7,049
Selling, general, and administrative	54,782	[2]	43,820
Total operating expenses	62,366		50,869
Operating loss	(15,126)		(9,062)
Other income (expense):
Other income (expense), net	515		(616)
Interest expense, net	(2,622)		(1,205)
Total other expense, net	(2,107)		(1,821)
Loss before income taxes	(17,233)		(10,883)
Income tax expense (benefit)	166	[3]	(71)
Net loss	(17,399)	[1],[2],[3]	(10,812)
Foreign currency translation adjustment	(1,097)		(99)
Comprehensive loss	$ (18,496)		$ (10,911)
Weighted average number of shares of common stock outstanding:
Basic	82,854,334		80,681,715
Diluted	82,854,334		80,681,715
Net loss per share attributable to common stockholders:
Basic	$ (0.21)		$ (0.13)
Diluted	$ (0.21)		$ (0.13)

[1] Inventory Treatment - The correction of the misstatement resulted in an increase to Cost of goods sold of $1,656 for the three-months ended March 31, 2024.

[2] Trade Receivable Reserve - The correction of the misstatement resulted in an increase to Selling, general and administrative of $567 for the three-months ended March 31, 2024.

[3] Income Tax Adjustment - The correction of the misstatement resulted in a decrease to Income tax expense (benefit) of $58 for the three-months ended March 31, 2024.